
The Allianz-backed company, which is developing treatments for inner ear disorders, has set the range for its initial public offering between $10 and $12.
The digital branding company cut the size of its shares prior to flotation, only to see the price rise after it went public.
The SingTel-backed digital advertising company has cut the range of its forthcoming initial public offering from $11-$13 to $7-$8.
Internet portal Naver is set to reap a huge return as its messaging app subsidiary files for an initial public offering that values it at almost $10bn.
The pharmaceutical company, which has Novo as its third largest shareholder, will seek to raise up to $86.3m.
Tiange Group, backed by IDG and Sina, aims to raise $207.7m in its forthcoming IPO, down from the $300m target the company set in February.
The Tencent and Legend-backed company, which claims to be China's largest mobile game publisher, will earmark some of the proceeds for acquisitions.
The pharmaceutical company raised $32.7m after floating at a price far below its range, while Janssen Pharmaceutica took a 17% stake.
Array Biopharma is among the shareholders of the cancer therapeutics developer after striking a development deal in July last year.
The Novo Nordisk-backed cancer drug developer has set a $75m target for its initial public offering and will use the proceeds to fund further research.